Andrea Sboner

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Patient-derived organoids across cancers reveal conserved tumor heterogeneity and actionable therapeutic vulnerabilities

  Science Advances · 2026-06-26

• Table S7 from Kinome-Focused CRISPR-Cas9 Screens in African Ancestry Patient-Derived Breast Cancer Organoids Identify Essential Kinases and Synergy of EGFR and FGFR1 Inhibition

  2026-06-17

• Table S2 from Kinome-Focused CRISPR-Cas9 Screens in African Ancestry Patient-Derived Breast Cancer Organoids Identify Essential Kinases and Synergy of EGFR and FGFR1 Inhibition

  2026-06-17

• Table S6 from Kinome-Focused CRISPR-Cas9 Screens in African Ancestry Patient-Derived Breast Cancer Organoids Identify Essential Kinases and Synergy of EGFR and FGFR1 Inhibition

  2026-06-17

• Table S5 from Kinome-Focused CRISPR-Cas9 Screens in African Ancestry Patient-Derived Breast Cancer Organoids Identify Essential Kinases and Synergy of EGFR and FGFR1 Inhibition

  2026-06-17

• Table S1 from Kinome-Focused CRISPR-Cas9 Screens in African Ancestry Patient-Derived Breast Cancer Organoids Identify Essential Kinases and Synergy of EGFR and FGFR1 Inhibition

  2026-06-17

• Table S4 from Kinome-Focused CRISPR-Cas9 Screens in African Ancestry Patient-Derived Breast Cancer Organoids Identify Essential Kinases and Synergy of EGFR and FGFR1 Inhibition

  2026-06-17

• Table S3 from Kinome-Focused CRISPR-Cas9 Screens in African Ancestry Patient-Derived Breast Cancer Organoids Identify Essential Kinases and Synergy of EGFR and FGFR1 Inhibition

  2026-06-17

• Tumor immune microenvironment reconstitution in patient-derived organoids enables therapy modeling for NSCLC

  Cell Reports Methods · 2026-05-14 · 1 citations

• Enhancing the quality and trustworthiness of large language model-generated summaries of clinical oncology literature

  JAMIA Open · 2026-05-05

• Precision Medicine

  CUNY Academic Works (City University of New York) · 2026-05-01

• Whole genome sequencing of locally advanced and metastatic breast carcinoma unravels relevant molecular signatures and novel events

  Pathology - Research and Practice · 2026-04-15

• Abstract 4062: MBD4 regulates FOXA1 lineage-specific enhancers to promote prostate tumorigenesis and progression

  Cancer Research · 2026-04-03

• Abstract 2453: Valproic acid enhances immune reprogramming in locally advanced rectal cancer: Insights from the VshoRTR3 trial

  Cancer Research · 2026-04-03

• Abstract A058: Integrating DNA-RNA sequencing analysis to identify low-variant allele frequency fusions in glioblastoma

  Cancer Research · 2026-03-23

• 1070 GLI1-Rearranged Low-Grade Endometrial Stromal Sarcoma A Rare and Aggressive Molecular Subtype?

  Laboratory Investigation · 2026-03-01

• 627 Comprehensive Characterization of NIPBL::NACC1 Fusion Hepatic Carcinoma: Further Evidence Supports a Distinct Entity

  Laboratory Investigation · 2026-03-01

• 1480 Cancer of Unknown Primary (CUP): Beyond the Identification of the Tumor of Origin by an Integrative Whole Exome (WES) and Transcriptome Sequencing (RNAseq) Approach

  Laboratory Investigation · 2026-03-01

• 795 Expression of CEACAM5 and TROP2 in Advanced Prostate Cancer: Heterogeneity and Correlation with Morphologic and Immunophenotypic Subtypes

  Laboratory Investigation · 2026-03-01

• Abstract A010: MBD4 regulates FOXA1 lineage-specific enhancers to promote prostate tumorigenesis and progression

  Cancer Research · 2026-01-20